🇺🇸 FDA
Patent

US 10407374

Compositions and methods for ameliorating CNS inflammation, psychosis, delirium, PTSD or PTSS

granted A61KA61K2039/505A61K31/12

Quick answer

US patent 10407374 (Compositions and methods for ameliorating CNS inflammation, psychosis, delirium, PTSD or PTSS) held by The Regents of the University of California expires Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K2039/505, A61K31/12, A61K31/192, A61K31/194